EBRI Notes (Vol. 34, No. 4, April 2013, .pdf format, 20p.). Note: The articles in this issue are: “Characteristics of the Population With Consumer-Driven and High-Deductible Health Plans, 2005-2012,” by Paul Fronstin; and, “Retirement Plan Participation and Asset Allocation, 2010,” by Craig Copeland.
www.ebri.org/publications/notes/index.cfm?fa=notesDisp&content_id=5202
A. “Spike bursts increase amyloid-{beta} 40/42 ratio by inducing a presenilin-1 conformational change,” by Iftach Dolev, Hilla Fogel, Hila Milshtein, Yevgeny Berdichevsky, Noa Lipstein, Nils Brose, Neta Gazit & Inna Slutsky (Vol. 16, No. 5, May 2013, p. 587-595).
www.nature.com/neuro/journal/v16/n5/abs/nn.3376.html
B. “Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-{beta},” by Elsa Suberbielle, Pascal E Sanchez, Alexxai V Kravitz, Xin Wang, Kaitlyn Ho, Kirsten Eilertson, Nino Devidze, Anatol C Kreitzer and Lennart Mucke (Vol. 16, No. 5, May 2013, p. 613-619).
www.nature.com/neuro/journal/v16/n5/abs/nn.3356.html
C. “Dopamine restores reward prediction errors in old age,” by Rumana Chowdhury, Marc Guitart-Masip, Christian Lambert, Peter Dayan, Quentin Huys, Emrah Düzel & Raymond J Dolan (Vol. 16, No. 5, May 2013, p. 648-653).
www.nature.com/neuro/journal/v16/n5/abs/nn.3364.html
D. “Activation of transposable elements during aging and neuronal decline in Drosophila,” by Wanhe Li, Lisa Prazak, Nabanita Chatterjee, Servan Gruninger, Lisa Krug, Delphine Theodorou & Josh Dubnau (Vol. 16, No. 5, May 2013, p. 529-531).
“Cohort mortality risk or adverse selection in the UK annuity market?” by Edmund Cannon and Ian Tonks (PI-1304, April 2013, .pdf format, 42p.).
Abstract:
The “money’s worth” measure has been used to assess whether annuities are fairly valued and also as evidence for adverse selection in the annuity market. However, a regulated life assurer with concerns about predicting long-run mortality may price annuities to reduce these risks which will affect the money’s worth. We provide a simple model of the effect of cohort mortality risk on the money’s worth. We demonstrate that cohort mortality risk is quantitatively important, and show that it is not possible to identify the effect of a cohort mortality risk model from that of an adverse selection model.
Gerontologist (Vol. 53, No. 3, June 2013).
gerontologist.oxfordjournals.org/content/53/3.toc
Journal of Alzheimer’s Disease (Vol. 35, No. 2, April 2013).
“Suppressing protein may stem Alzheimer’s disease process” (Apr. 25, 2013).
Powered by WordPress
